Hudson Bay Capital Management
KPRX icon

Hudson Bay Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Hudson Bay Capital Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-912
Closed -$3.29M – 549
2019
Q4 		$3.29M Buy
+912
New +$1.77M 0.07% 228

Other funds holding KPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $915M AUM 19.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hudson Bay Capital Management's KPRX Position: Q1 2020 in Review

Hudson Bay Capital Management sold out of Kiora Pharmaceuticals (KPRX) in Q1 2020, closing a stake of 912 shares — an estimated $3.29M sold.

Hudson Bay Capital Management first reported a position in KPRX in Q4 2019 and held it in 1 quarter. The position peaked at $3.29M in Q4 2019. 12 funds tracked by Wall St. Rank hold KPRX as of Q1 2020.

  • Hudson Bay Capital Management reported no remaining Kiora Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 912 Kiora Pharmaceuticals shares in Q1 2020, an estimated $3.29M.
  • Hudson Bay Capital Management first reported a position in Kiora Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Hudson Bay Capital Management's Kiora Pharmaceuticals position peaked at $3.29M in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2020.

Based on Hudson Bay Capital Management's 13F filing for Q1 2020, filed 14 May 2020.